InsiderClue
← All stocks

Medpace Holdings, Inc.

MEDP Net selling
CIK 0001668397 #724 in the set updated 17 Sep 2026
Bought (120 mo)
$309.19M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.60B
$288.08M on a plan · $135.21M straight out of an exercise
Sold at will
$3.18B
431 of 500 sales
Net
−$3.30B
−$2.87B against sales at will

By person

16 insiders · 603 transactions
6,620×

August J. Troendle holds 6,620 times base salary in stock. $6.21B of shares against $937.42K in salary for 2025.

Salary from the company's own proxy. The shares are what August J. Troendle last reported holding, valued at $620.27, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Troendle August J.
President & CEO
$154.56M (17)
$1.38B (230)
−$1.23B
10,005,932
35.85%
$6.21B
−34.0%
Medpace Limited Partnership entity
10% owner
—
$998.48M (6)
−$998.48M
0
0.0000%
$0.00
−100.0%
Medpace Investors, LLC entity
10% owner
$154.56M (17)
$999.64M (179)
−$845.08M
4,733,019
16.96%
$2.94B
−48.6%
GEIGER JESSE J
President
—
$83.46M (22) scheduled
−$83.46M
15,000
0.0537%
$9.30M
—
BURWIG SUSAN E
Exec. VP, Operations
—
$61.14M (17)
−$61.14M
62,984
0.2257%
$39.07M
+227.9%
EWALD STEPHEN P
General Counsel & Corp. Secy.
$652.22 (1)
$33.36M (15) scheduled
−$33.36M
20,343
0.0729%
$12.62M
—
Kraft Robert O.
Director
—
$15.18M (6) scheduled
−$15.18M
955
0.0034%
$592.36K
—
Brady Kevin M.
CFO & Treasurer
—
$11.87M (7) scheduled
−$11.87M
12,830
0.0460%
$7.96M
+156.6%
DAVENPORT FRED B JR
Director
$72.90K (1)
$8.41M (3) scheduled
−$8.33M
5,798
0.0208%
$3.60M
+286.5%
Carley Brian T
Director
—
$4.43M (2)
−$4.43M
27,825
0.0997%
$17.26M
—
McCarthy Cornelius P. III
Director
—
$1.93M (3)
−$1.93M
12,275
0.0440%
$7.61M
—
Keating Ashley M.
Director
—
$1.69M (8) scheduled
−$1.69M
250
0.0009%
$155.07K
—
King Tom C
Director
—
$79.60K (2) scheduled
−$79.60K
598
0.0021%
$370.92K
—
Brown Bruce
Director
—
—
—
9,295
0.0333%
$5.77M
—
BUCKNELL PENELOPE J
VP, Human Resources
—
—
—
3,000
0.0107%
$1.86M
—
Fifth Cinven Fund (No. 1) Limited Partnership entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

141
Insider
Date
Role
Action
Shares
Price
Amount
Troendle August J.
27 Aug 2026
President & CEO
Sell
650
$620.27
$403.18K
Troendle August J.
26 Aug 2026
President & CEO
Sell
4,000
$620.03
$2.48M
Troendle August J.
25 Aug 2026
President & CEO
Sell
673
$620.38
$417.52K
Troendle August J.
24 Aug 2026
President & CEO
Sell
1,983
$620.23
$1.23M
Troendle August J.
21 Aug 2026
President & CEO
Sell
13,995
$624.45
$8.74M
Troendle August J.
20 Aug 2026
President & CEO
Sell
27,174
$618.79
$16.81M
Carley Brian T
19 Aug 2026
Director
Sell
5,000
$608.63
$3.04M
Troendle August J.
19 Aug 2026
President & CEO
Sell
15,609
$606.47
$9.47M
Troendle August J.
13 Aug 2026
President & CEO
Sell
458
$600.39
$274.98K
Troendle August J.
12 Aug 2026
President & CEO
Sell
11,366
$601.53
$6.84M
Troendle August J.
11 Aug 2026
President & CEO
Sell
17,610
$605.11
$10.66M
McCarthy Cornelius P. III
11 Aug 2026
Director
Sell
1,140
$605.37
$690.12K
Troendle August J.
10 Aug 2026
President & CEO
Sell
5,534
$601.53
$3.33M
BURWIG SUSAN E
28 Jul 2026
Exec. VP, Operations
Sell
7,500
$600.00
$4.50M
Troendle August J.
28 Jul 2026
President & CEO
Sell
3,510
$600.01
$2.11M
Troendle August J.
27 Jul 2026
President & CEO
Sell
3,728
$600.85
$2.24M
Troendle August J.
3 Dec 2025
CEO
Sell
668
$590.69
$394.58K
Troendle August J.
2 Dec 2025
CEO
Sell
5,698
$590.47
$3.36M
Troendle August J.
1 Dec 2025
CEO
Sell
23,178
$593.25
$13.75M
Troendle August J.
28 Nov 2025
CEO
Sell
15,151
$593.46
$8.99M
Troendle August J.
26 Nov 2025
CEO
Sell
41,331
$606.88
$25.08M
Troendle August J.
25 Nov 2025
CEO
Sell
42,392
$615.52
$26.09M
BURWIG SUSAN E
24 Nov 2025
Exec. VP, Operations
Sell
20,000
$609.15
$12.18M
Troendle August J.
24 Nov 2025
CEO
Sell
59,025
$607.78
$35.87M
Troendle August J.
21 Nov 2025
CEO
Sell
21,858
$592.18
$12.94M
Troendle August J.
20 Nov 2025
CEO
Sell
6,830
$598.49
$4.09M
Troendle August J.
19 Nov 2025
CEO
Sell
23,862
$592.07
$14.13M
Troendle August J.
18 Nov 2025
CEO
Sell
7,191
$590.84
$4.25M
Troendle August J.
17 Nov 2025
CEO
Sell
6,047
$591.00
$3.57M
Troendle August J.
14 Nov 2025
CEO
Sell
14,747
$595.26
$8.78M
Troendle August J.
13 Nov 2025
CEO
Sell
5,128
$601.37
$3.08M
Troendle August J.
12 Nov 2025
CEO
Sell
5,312
$603.23
$3.20M
BURWIG SUSAN E
11 Nov 2025
Exec. VP, Operations
Sell
18,000
$605.00
$10.89M
BURWIG SUSAN E
27 Oct 2025
Exec. VP, Operations
Sell
2,000
$605.01
$1.21M
BURWIG SUSAN E
3 Sep 2025
Exec. VP, Operations
Sell
10,000
$480.00
$4.80M
Troendle August J.
2 Sep 2025
CEO
Sell
1,197
$475.11
$568.71K
Troendle August J.
29 Aug 2025
CEO
Sell
36,196
$475.90
$17.23M
Troendle August J.
27 Aug 2025
CEO
Sell
620
$475.00
$294.50K
McCarthy Cornelius P. III
19 Aug 2025
Director
Sell
1,662
$465.04
$772.90K
Troendle August J.
28 Jul 2025
CEO
Sell
48,487
$451.69
$21.90M
BURWIG SUSAN E
28 Jul 2025
Exec. VP, Operations
Sell
7,500
$450.14
$3.38M
EWALD STEPHEN P
28 Jul 2025
General Counsel & Corp. Secy.
Sell
3,000
$450.00
$1.35M
BURWIG SUSAN E
5 Jun 2024
Exec. VP, Operations
Sell
7,681
$401.20
$3.08M
Troendle August J.
28 May 2024
CEO
Sell
5,695
$395.49
$2.25M
Troendle August J.
24 May 2024
CEO
Sell
3,987
$395.22
$1.58M
Troendle August J.
22 May 2024
CEO
Sell
55
$400.00
$22.00K
Troendle August J.
20 May 2024
CEO
Sell
4,020
$400.19
$1.61M
Troendle August J.
16 May 2024
CEO
Sell
7,060
$403.09
$2.85M
Troendle August J.
15 May 2024
CEO
Sell
32,282
$405.13
$13.08M
Troendle August J.
10 May 2024
CEO
Sell
4,956
$402.89
$2.00M
Troendle August J.
9 May 2024
CEO
Sell
3,486
$400.17
$1.39M
Troendle August J.
8 May 2024
CEO
Sell
4,782
$400.58
$1.92M
Troendle August J.
7 May 2024
CEO
Sell
28,032
$404.48
$11.34M
Troendle August J.
6 May 2024
CEO
Sell
24,372
$401.73
$9.79M
Troendle August J.
2 May 2024
CEO
Sell
3,396
$400.44
$1.36M
Troendle August J.
1 May 2024
CEO
Sell
12,934
$401.56
$5.19M
Troendle August J.
30 Apr 2024
CEO
Sell
1,828
$400.31
$731.77K
Troendle August J.
29 Apr 2024
CEO
Sell
15,102
$400.69
$6.05M
BURWIG SUSAN E
15 Mar 2024
Exec. VP, Operations
Sell
102
$403.00
$41.11K
Medpace Investors, LLC
8 Mar 2024
10% owner
Sell
25,000
$408.71
$10.22M
Troendle August J.
8 Mar 2024
CEO
Sell indirect
25,000
$408.71
$10.22M
Medpace Investors, LLC
7 Mar 2024
10% owner
Sell
75,000
$410.74
$30.81M
Troendle August J.
7 Mar 2024
CEO
Sell indirect
75,000
$410.74
$30.81M
Medpace Investors, LLC
6 Mar 2024
10% owner
Sell
100,000
$412.98
$41.30M
Troendle August J.
6 Mar 2024
CEO
Sell indirect
100,000
$412.98
$41.30M
Medpace Investors, LLC
5 Mar 2024
10% owner
Sell
50,000
$402.70
$20.14M
Troendle August J.
5 Mar 2024
CEO
Sell indirect
50,000
$402.70
$20.14M
Medpace Investors, LLC
4 Mar 2024
10% owner
Sell
50,000
$403.12
$20.16M
Troendle August J.
4 Mar 2024
CEO
Sell indirect
50,000
$403.12
$20.16M
EWALD STEPHEN P
1 Mar 2024
General Counsel & Corp. Secy.
Sell
350
$400.79
$140.28K
Troendle August J.
1 Mar 2024
CEO
Sell indirect
80,000
$401.88
$32.15M
Medpace Investors, LLC
1 Mar 2024
10% owner
Sell
80,000
$401.88
$32.15M
GEIGER JESSE J
29 Feb 2024
President
Sell
2,558
$393.51
$1.01M
EWALD STEPHEN P
29 Feb 2024
General Counsel & Corp. Secy.
Sell
1,163
$393.51
$457.65K
Troendle August J.
29 Feb 2024
CEO
Sell indirect
20,000
$393.71
$7.87M
Medpace Investors, LLC
29 Feb 2024
10% owner
Sell
20,000
$393.71
$7.87M
Medpace Investors, LLC
28 Feb 2024
10% owner
Sell
50,000
$404.13
$20.21M
Troendle August J.
28 Feb 2024
CEO
Sell indirect
50,000
$404.13
$20.21M
Medpace Investors, LLC
27 Feb 2024
10% owner
Sell
50,000
$401.88
$20.09M
Troendle August J.
27 Feb 2024
CEO
Sell indirect
50,000
$401.88
$20.09M
Medpace Investors, LLC
26 Feb 2024
10% owner
Sell
56,928
$402.38
$22.91M
Troendle August J.
26 Feb 2024
CEO
Sell indirect
56,928
$402.38
$22.91M
Medpace Investors, LLC
23 Feb 2024
10% owner
Sell
100,000
$400.32
$40.03M
Troendle August J.
23 Feb 2024
CEO
Sell indirect
100,000
$400.32
$40.03M
Troendle August J.
22 Feb 2024
CEO
Sell indirect
100,000
$395.98
$39.60M
Medpace Investors, LLC
22 Feb 2024
10% owner
Sell
100,000
$395.98
$39.60M
Troendle August J.
21 Feb 2024
CEO
Sell indirect
36,012
$383.44
$13.81M
Medpace Investors, LLC
21 Feb 2024
10% owner
Sell
36,012
$383.44
$13.81M
Troendle August J.
20 Feb 2024
CEO
Sell indirect
13,988
$386.39
$5.40M
Medpace Investors, LLC
20 Feb 2024
10% owner
Sell
13,988
$386.39
$5.40M
Troendle August J.
16 Feb 2024
CEO
Sell indirect
50,000
$391.75
$19.59M
Medpace Investors, LLC
16 Feb 2024
10% owner
Sell
50,000
$391.75
$19.59M
BURWIG SUSAN E
15 Dec 2023
Exec. VP, Operations
Sell
2,009
$303.00
$608.73K
BURWIG SUSAN E
14 Dec 2023
Exec. VP, Operations
Sell
10,391
$304.15
$3.16M
Medpace Investors, LLC
1 Dec 2023
10% owner
Sell
24,039
$273.26
$6.57M
Troendle August J.
1 Dec 2023
CEO
Sell indirect
24,039
$273.26
$6.57M
Medpace Investors, LLC
30 Nov 2023
10% owner
Sell
7,871
$272.18
$2.14M
Troendle August J.
30 Nov 2023
CEO
Sell indirect
7,871
$272.18
$2.14M
Medpace Investors, LLC
29 Nov 2023
10% owner
Sell
18,090
$272.62
$4.93M
Medpace Investors, LLC
29 Nov 2023
10% owner
Sell
3,167
$272.87
$864.18K
Troendle August J.
29 Nov 2023
CEO
Sell indirect
18,090
$272.62
$4.93M
Troendle August J.
29 Nov 2023
CEO
Sell indirect
3,167
$272.87
$864.18K
Troendle August J.
28 Nov 2023
CEO
Sell indirect
21,833
$273.66
$5.97M
Medpace Investors, LLC
28 Nov 2023
10% owner
Sell
21,833
$273.66
$5.97M
Troendle August J.
27 Nov 2023
CEO
Sell indirect
25,000
$276.10
$6.90M
Medpace Investors, LLC
27 Nov 2023
10% owner
Sell
25,000
$276.10
$6.90M
Medpace Investors, LLC
22 Nov 2023
10% owner
Sell
25,000
$277.81
$6.95M
Troendle August J.
22 Nov 2023
CEO
Sell indirect
25,000
$277.81
$6.95M
Troendle August J.
21 Nov 2023
CEO
Sell indirect
25,000
$277.37
$6.93M
Medpace Investors, LLC
21 Nov 2023
10% owner
Sell
25,000
$277.37
$6.93M
Troendle August J.
20 Nov 2023
CEO
Sell indirect
50,000
$275.45
$13.77M
Medpace Investors, LLC
20 Nov 2023
10% owner
Sell
50,000
$275.45
$13.77M
Troendle August J.
17 Nov 2023
CEO
Sell indirect
50,000
$273.91
$13.70M
Medpace Investors, LLC
17 Nov 2023
10% owner
Sell
50,000
$273.91
$13.70M
Medpace Investors, LLC
16 Nov 2023
10% owner
Sell
17,000
$281.61
$4.79M
Troendle August J.
16 Nov 2023
CEO
Sell indirect
17,000
$281.61
$4.79M
Medpace Investors, LLC
15 Nov 2023
10% owner
Sell
33,000
$283.42
$9.35M
Troendle August J.
15 Nov 2023
CEO
Sell indirect
33,000
$283.42
$9.35M
Medpace Investors, LLC
14 Nov 2023
10% owner
Sell
25,000
$283.11
$7.08M
Troendle August J.
14 Nov 2023
CEO
Sell indirect
25,000
$283.11
$7.08M
Brady Kevin M.
16 Nov 2022
CFO & Treasurer
Sell
344
$227.09
$78.12K
Brady Kevin M.
15 Nov 2022
CFO & Treasurer
Sell
1,656
$229.30
$379.72K
Medpace Investors, LLC
4 Jan 2022
10% owner
Sell
3,338
$213.44
$712.46K
Troendle August J.
4 Jan 2022
CEO
Sell indirect
3,338
$213.44
$712.46K
Medpace Investors, LLC
3 Jan 2022
10% owner
Sell
19,744
$212.70
$4.20M
Troendle August J.
3 Jan 2022
CEO
Sell indirect
19,744
$212.70
$4.20M
Medpace Investors, LLC
31 Dec 2021
10% owner
Sell
13,069
$219.14
$2.86M
Troendle August J.
31 Dec 2021
CEO
Sell indirect
13,069
$219.14
$2.86M
Medpace Investors, LLC
30 Dec 2021
10% owner
Sell
17,376
$220.34
$3.83M
Troendle August J.
30 Dec 2021
CEO
Sell indirect
17,376
$220.34
$3.83M
Medpace Investors, LLC
29 Dec 2021
10% owner
Sell
16,750
$220.16
$3.69M
Troendle August J.
29 Dec 2021
CEO
Sell indirect
16,750
$220.16
$3.69M
Medpace Investors, LLC
28 Dec 2021
10% owner
Sell
24,118
$222.18
$5.36M
Troendle August J.
28 Dec 2021
CEO
Sell indirect
24,118
$222.18
$5.36M
Medpace Investors, LLC
27 Dec 2021
10% owner
Sell
39,171
$226.11
$8.86M
Troendle August J.
27 Dec 2021
CEO
Sell indirect
39,171
$226.11
$8.86M
Medpace Investors, LLC
23 Dec 2021
10% owner
Sell
22,830
$223.19
$5.10M
Troendle August J.
23 Dec 2021
CEO
Sell indirect
22,830
$223.19
$5.10M
Medpace Investors, LLC
22 Dec 2021
10% owner
Sell
38,960
$220.50
$8.59M
Troendle August J.
22 Dec 2021
CEO
Sell indirect
38,960
$220.50
$8.59M
Medpace Investors, LLC
21 Dec 2021
10% owner
Sell
18,133
$215.17
$3.90M
Showing 250 of 603 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 521
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 52
Sales at will 431
Transactions with no price 0
Shares from compensation/vesting 26,761,827
Sales filed before the plan box existed 311
History held since 3 Nov 2016